Beyond Novo: Fund manager likes this under-the-radar pharma stock with a weight loss drug in the works
- Posted on October 3, 2024
- By CNBC
- 1 Views
Beyond Novo: Fund manager likes this under-the-radar pharma stock with a weight loss drug in the works
"We like to go find better value in the road less travelled," Sean Peche of Ranmore Fund Management says of the stock. Analysts give it nearly 30% upside.
